U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C38H42N8O6S2
Molecular Weight 770.92
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of BISBENTIAMINE

SMILES

C\C(N(CC1=CN=C(C)N=C1N)C=O)=C(\CCOC(=O)C2=CC=CC=C2)SS\C(CCOC(=O)C3=CC=CC=C3)=C(/C)N(CC4=C(N)N=C(C)N=C4)C=O

InChI

InChIKey=IWXAZSAGYJHXPX-BCEWYCLDSA-N
InChI=1S/C38H42N8O6S2/c1-25(45(23-47)21-31-19-41-27(3)43-35(31)39)33(15-17-51-37(49)29-11-7-5-8-12-29)53-54-34(16-18-52-38(50)30-13-9-6-10-14-30)26(2)46(24-48)22-32-20-42-28(4)44-36(32)40/h5-14,19-20,23-24H,15-18,21-22H2,1-4H3,(H2,39,41,43)(H2,40,42,44)/b33-25+,34-26+

HIDE SMILES / InChI

Description

Bisbentiamine is an O-benzoyl thiamine disulfide or vitamin B1 disulfide derivative. Thiamine derivatives and thiamine-dependent enzymes are present in all cells of the body, thus a thiamine deficiency would seem to adversely affect all of the organ systems. Lipid-soluble thiamine precursors such as Bisbentiamine have a much higher bioavailability than genuine thiamine and therefore are more suitable for therapeutic purposes. It is also used as a dietary supplement.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Beston

PubMed

Sample Use Guides

In Vivo Use Guide
The recommended adult daily dose is 1-4 tablets (25-100 mg) given orally.
Route of Administration: Oral
In Vitro Use Guide
1 ug of Bisbentiamine (BTDS) was incubated with L. ferinenti 36 and L. viridescens S38A for 24 hours at 37 C to measure the growth of these microorganisms.